Recent Quarter Total Invested
$2.15 B
Recent Quarter Institutional Ownership Percentage
94.97%
Total Invested of Last Quarter
$1.03 B
Ownership Percentage of Last Quarter
85.57%
Day One Biopharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 11/14/2024 | 7.87 M | $109.65 M | 0.00% | 8.15% |
| ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC | 11/13/2024 | 6.43 M | $89.57 M | 0.00% | 6.66% |
| BRAIDWELL LP | 11/14/2024 | 4.87 M | $67.89 M | 60.54% | 5.04% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 4.71 M | $65.60 M | 100.00% | 4.87% |
| FRANKLIN RESOURCES INC | 11/12/2024 | 3.87 M | $55.34 M | 2.31% | 4.00% |
| FAIRMOUNT FUNDS MANAGEMENT LLC | 11/14/2024 | 3.10 M | $43.23 M | 100.00% | 3.21% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/12/2024 | 2.98 M | $41.55 M | 4.60% | 3.09% |
| STATE STREET CORP | 11/14/2024 | 2.82 M | $39.34 M | -0.11% | 2.92% |
| ESTUARY CAPITAL MANAGEMENT LP | 11/14/2024 | 2.74 M | $38.22 M | 4.12% | 2.84% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 11/14/2024 | 2.62 M | $36.46 M | -10.45% | 2.71% |
| VIKING GLOBAL INVESTORS LP | 11/14/2024 | 2.56 M | $35.64 M | 0.00% | 2.65% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 2.54 M | $35.45 M | 8.25% | 2.63% |
| VESTAL POINT CAPITAL, LP | 11/14/2024 | 2.50 M | $34.83 M | 100.00% | 2.59% |
| JANUS HENDERSON GROUP PLC | 11/14/2024 | 2.18 M | $30.31 M | 18.37% | 2.25% |
| MAVERICK CAPITAL LTD | 11/14/2024 | 2.11 M | $29.45 M | 74.55% | 2.19% |
| TIMESSQUARE CAPITAL MANAGEMENT, LLC | 11/04/2024 | 1.83 M | $25.46 M | 8.24% | 1.89% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 1.77 M | $24.72 M | -6.77% | 1.84% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 1.43 M | $19.96 M | 10.53% | 1.48% |
| BOXER CAPITAL, LLC | 11/14/2024 | 1.19 M | $16.58 M | 0.00% | 1.23% |
| FIRST TURN MANAGEMENT, LLC | 11/07/2024 | 947,878 | $13.20 M | 100.00% | 0.98% |
| PARKMAN HEALTHCARE PARTNERS LLC | 11/14/2024 | 924,140 | $12.87 M | 1.69% | 0.96% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2024 | 900,000 | $12.54 M | 100.00% | 0.93% |
| ECOR1 CAPITAL, LLC | 11/14/2024 | 862,068 | $12.01 M | 100.00% | 0.89% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 836,195 | $11.65 M | -5.85% | 0.87% |
| WOODLINE PARTNERS LP | 11/14/2024 | 797,333 | $11.11 M | 12.69% | 0.83% |
| MORGAN STANLEY | 11/14/2024 | 774,511 | $10.79 M | 363.10% | 0.80% |
| DAFNA CAPITAL MANAGEMENT LLC | 11/14/2024 | 750,363 | $10.45 M | 12.59% | 0.78% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 721,581 | $10.05 M | 142.11% | 0.75% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 11/13/2024 | 720,108 | $10.03 M | 29.72% | 0.75% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 11/15/2024 | 689,655 | $9.61 M | 100.00% | 0.71% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 11/14/2024 | 526,732 | $7.34 M | -25.44% | 0.55% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 507,448 | $7.07 M | 14.61% | 0.53% |
| STEMPOINT CAPITAL LP | 11/13/2024 | 506,978 | $7.06 M | 100.00% | 0.52% |
| CITADEL ADVISORS LLC | 11/14/2024 | 484,261 | $6.75 M | 31.02% | 0.50% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 407,501 | $5.68 M | 36.19% | 0.42% |
| SPHERA FUNDS MANAGEMENT LTD. | 11/14/2024 | 347,627 | $4.84 M | 0.00% | 0.36% |
| PFM HEALTH SCIENCES, LP | 11/14/2024 | 342,172 | $4.77 M | -13.73% | 0.35% |
| CANDRIAM S.C.A. | 11/13/2024 | 290,014 | $4.04 M | 0.00% | 0.30% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 11/13/2024 | 205,675 | $2.87 M | 100.00% | 0.21% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 192,194 | $2.68 M | 8.18% | 0.20% |
| KENNEDY CAPITAL MANAGEMENT LLC | 11/14/2024 | 189,297 | $2.64 M | 8.96% | 0.20% |
| POLAR CAPITAL HOLDINGS PLC | 11/14/2024 | 185,000 | $2.58 M | -80.21% | 0.19% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 10/10/2024 | 184,230 | $2.57 M | 100.00% | 0.19% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 170,738 | $2.38 M | -18.07% | 0.18% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 163,698 | $2.28 M | -14.25% | 0.17% |
| SAMSARA BIOCAPITAL, LLC | 11/14/2024 | 147,319 | $2.05 M | -25.00% | 0.15% |
| D. E. SHAW & CO., INC. | 11/14/2024 | 143,135 | $1.99 M | -36.20% | 0.15% |
| RAFFERTY ASSET MANAGEMENT, LLC | 11/13/2024 | 136,433 | $1.90 M | -8.84% | 0.14% |
| BARCLAYS PLC | 11/19/2024 | 135,373 | $1.89 M | 143.50% | 0.14% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2024 | 130,310 | $1.82 M | 15.30% | 0.13% |
Day One Biopharmaceuticals, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of DAWN shares?
During the previous two years, 186 institutional investors and hedge funds held shares of Day One Biopharmaceuticals, Inc.. The most heavily invested institutionals were:
RA CAPITAL MANAGEMENT, L.P.: 7.87 M
Atlas Venture Life Science Advisors, LLC: 6.43 M
BRAIDWELL LP: 4.87 M
BlackRock Funding, Inc. /DE: 4.71 M
FRANKLIN RESOURCES INC: 3.87 M
Fairmount Funds Management LLC: 3.1 M
-
What percentage of Day One Biopharmaceuticals, Inc. stock is owned by institutional investors?
94.97% of Day One Biopharmaceuticals, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at DAWN ?
Institutional investors have bought a total of 82.37 M shares in the last 24 months. This purchase volume represents approximately $1.13 B in transactions.